Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2012
Operating activities:
Net income (loss)	$ (239,393)	$ (209,467)	$ (167,575)
Reconciliation of net income (loss) to cash provided by operating activities:
Depreciation, amortization, and accretion	129,595	155,015	116,912
Impairments of long-lived assets	18,172	44,158	34,842
Impairment of goodwill	106,205	177,006	64,295	$ 64,295
Provision (benefit) for deferred income taxes	(1,808)	(379)	(350)
Equity-based compensation expense	13,747	16,887	6,775
Provision for doubtful accounts	2,436	5,387	856
Excess decommissioning/abandoning costs	2,629	2,661	72,724
Other non-cash charges and credits	1,724	4,271	(3,782)
Amortization of deferred financing costs	4,141	3,961	2,968
Equity financing transaction fees	(4,066)
Paid-in-Kind Interest	2,659	0	0
Liabilities, Fair Value Adjustment	4,404	0	0
Fair Value Adjustment of Warrants	2,106	0	0
Acquisition and financing costs	0	0		$ 9,869
(Gain) loss on sale of property, plant, and equipment	(5,461)	(4,375)	(11)
Gain (Loss) on Extinguishment of Debt	1,400
Changes in operating assets and liabilities, net of assets acquired:
Accounts receivable	64,331	38,025	(7,866)
Inventories	1,384	70,431	(21,528)
Prepaid expenses and other current assets	3,348	(1,806)	(197)
Trade accounts payable and accrued expenses	(55,771)	(98,407)	67,508
Decommissioning liabilities	(4,040)	(10,305)	(63,319)
Other	(494)	2,888	(3,476)
Net cash provided by operating activities	53,980	195,951	108,645
Investing activities:
Purchases of property, plant, and equipment	(21,066)	(120,597)	(131,609)
Acquisition of businesses, net of cash acquired	0	0	(854,031)
Proceeds from sale of property, plant, and equipment	3,354	7,135	17,527
Other investing activities	3,456	(1,525)	374
Net cash provided by (used in) investing activities	(14,256)	(114,987)	(967,739)
Financing activities:
Proceeds from long-term debt	458,580	535,896	837,519
Principal payments on long-term debt	(689,783)	(598,070)	(289,900)
Proceeds from issuance of CCLP common units, net of underwriters' discount	0	0	363,149
CCLP distributions	(28,956)	(37,816)	(12,569)
Proceeds from issuance of common stock, net of underwriters' discount	168,275	0	0
Proceeds from Convertible Debt, net of offering costs	66,935	0	0
Proceeds from sale of common stock and exercise of stock options	68	303	1,032
Financing costs and other financing activities	(6,073)	(3,750)	(27,587)
Net cash provided by (used in) financing activities	(30,954)	(103,437)	871,644
Effect of exchange rate changes on cash	(1,987)	(2,854)	(2,920)
Increase (decrease) in cash and cash equivalents	6,783	(25,327)	9,630
Cash and cash equivalents at beginning of period	23,057	48,384	38,754
Cash and cash equivalents at end of period	29,840	23,057	48,384
Supplemental cash flow information:
Interest paid	54,506	52,491	33,092
Taxes paid (refunded)	$ 4,254	$ 6,710	$ 8,729